TrialThe New England journal of medicine2014
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2,272 papers cite itlatest 60 shown
this paperpooled ittrialcites it